ObjectiveTo provide evidence-based consensus guidelines for the management of women
with cervical cytological abnormalities and cervical cancer precursors.ParticipantsA panel of …

Objective: The study was undertaken to provide consensus guidelines for the management
of women with histologically confirmed cervical intraepithelial neoplasia (CIN) that can act as …

A group of 146 experts representing 29 organizations and professional societies met
September 18-19, 2006, in Bethesda, MD, to develop revised evidence-based, consensus …

Background Among women infected with the human immunodeficiency virus (HIV), there is
a high prevalence of human papillomavirus (HPV) infections. However, little is known about …

… Text for this article was first published in Wright TC Jr, Massad LS, Dunton CJ, Spitzer M,
Wilkerson EJ, Solomon D. 2006 Consensus guidelines for the management of women with …

Background Knowledge about the distribution of human papillomavirus (HPV) genotypes in
invasive cervical cancer is crucial to guide the introduction of prophylactic vaccines. We …

Human papillomavirus (HPV) DNA testing was recently approved by the Food and Drug
Administration for use as an adjunct to cytology for cervical cancer screening. To help provide …

ContextMore than half of the women diagnosed as having cervical cancer in the United States
have not been screened within the last 3 years, despite many having had contact with the …

… Thomas Wright had full access to all of the data in the study and takes … Wright and Behrens
contributed equally to the manuscript. Drs. Stoler, Sharma, Zhang and Teresa Wright provided …

… Text for this article was first published in Wright TC, Jr, Massad LS, Dunton CJ, Spitzer M,
Wilkinson EJ, Solomon D. 2006 Consensus Guidelines for the Management of Women with …